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Low-nutrient media and long incubation times facili-
tated the cultivation of 20 taxonomically diverse
Gram-negative marine bacteria within the phyla
Bacteroidetes and Proteobacteria. These strains
comprise as many as three new families and include
members of clades that had only been observed
using culture-independent techniques. Chemical
studies of the type strains representing two new fam-
ilies within the orderCytophagales led to the isolation
of nine new alkaloid secondary metabolites that can
be grouped into four distinct structure classes,
including azepinones, aziridines, quinolones, and
pyrazinones. Several of these compounds possess
antibacterial properties and appear, on structural
grounds, to be produced by amino acid-based
biosynthetic pathways. Our results demonstrate
that relatively simple cultivation techniques can
lead to the isolation of new bacterial taxa that are
capable of the production of alkaloid secondary me-
tabolites with antibacterial activities. These findings
support continued investment in cultivation tech-
niques as a method for natural product discovery.
INTRODUCTION
Bacteria encompass extraordinary levels of phylogenetic diver-
sity, the vast majority of which has yet to be cultured (Rappe´
and Giovannoni, 2003). In recent years, however, methodologies
involving dilution cultivation (Rappe´ et al., 2002), the simulation
of natural environments (Kaeberlein et al., 2002; Stevenson
et al., 2004; Janssen et al., 2002), micro-droplet cell encapsula-
tion (Zengler et al., 2002), and the application of creative sam-
pling devices (Nichols et al., 2010; Aoi et al., 2009; Gavrish
et al., 2008; Bollmann et al., 2007), have led to important ad-
vances in bacterial cultivation. The application of new tech-
niques such as these is also providing opportunities for natural1270 Chemistry & Biology 22, 1270–1279, September 17, 2015 ª201product discovery, as recently demonstrated by the discovery
of the antibiotic teixobactin (Ling et al., 2015). These methods
generally avoid the use of traditional, high-nutrient media in favor
of more environmentally relevant culture conditions for initial
strain isolation. The results make clear that many new groups
of bacteria will be available for laboratory-based study if the
appropriate cultivation conditions and time course of isolation
are employed. Given the historical importance of bacteria as a
source of clinically relevant antibiotics (Be´rdy, 2005), continued
advances in cultivation will likely coincide with increased oppor-
tunities for antibiotic discovery.
We previously demonstrated that low-nutrient media
improved the cultivation of algae-associated marine bacteria
(Jensen et al., 1996). Using a similar approach coupled with
extended agar plate incubation periods, we recently cultivated
and named two new families of marine bacteria, the Mooreia-
ceae and Catalimonadaceae, within the phylum Bacteroidetes
(Choi et al., 2013). Here, we report the isolation of additional,
previously uncultured marine bacterial taxa within the phyla
Bacteroidetes and Proteobacteria. Some of these strains are
closely related to bacteria that have only been detected using
culture-independent approaches, and thus help to bridge the
gap between what can be detected in the environment and
what can be studied in the laboratory. Organic extracts of
some of these bacterial cultures demonstrated antibiotic activity
and led to the isolation of new alkaloidal secondary metabolites,
several of which possess new carbon skeletons. These studies
further illustrate that new bacterial taxa can be readily isolated
using relatively simple cultivation techniques, and that Gram-
negative bacteria represent a promising resource for antibiotic
discovery, which has traditionally targeted Gram-positive
actinomycetes.RESULTS
Bacterial Cultivation
Using a variety of seawater-based media, we isolated 20 strains
of Gram-negative bacteria from various marine sources
including sediments, algal surfaces, and invertebrates (Tables
S1 and S2). Colonies with yellow to orange pigmentation and a
variety of colony morphologies ranging from highly wrinkled to5 Elsevier Ltd All rights reserved
Figure 1. Colony Morphologies of Gram-Negative Strains on Agar Plates and in Liquid Media
(A) Colonies isolated frommarine sediment on P1 agar plate. (B) Colonies isolated frommarine sediment on P4 agar plate. (C1, C2) Colonies of strain CNU-872 on
P1 agar plates. (D) Colonies of strain CNU-893 on P1 agar. (E1, E2) Colony morphologies of strain CNX-216T on P1 and Nutrient agar plates, respectively. (F1, F2)
Colonies of strain CUA-101 on P8 agar plates. (G1, G2) Colonies of strain CUA-116 on P9 agar plates. (H) Isolated strain CUA-117 on P1 agar. (I) Colonies of strain
CUA-158 on P10 agar. (J1, J2) Colonies of strain CUA-171 on P9 agar plates. (K1, K2) Colonies of strain CUA-420 on P4 agar plates. (L) Colonies of strain CUA-
466 on P7 agar. (M1, M2) Colonies of strain CUA-621 on P7 agar plates. (N1, N2) Colonies of strain TAA-239 on P5 agar plates. (O1, O2) Cultured Gram-negative
bacteria in liquid media.smooth and shiny were targeted (Figure 1). These colonies were
generally observed on agar plates following incubation periods
of 3 weeks to 2 months. As has been observed in the cultivation
of soil- and marine-derived bacteria (Buerger et al., 2012), we
also observed that numerous marine colonies were recovered
toward the end of the monitoring period, illustrating that
extended incubation times, often to several months, can be
required for colony formation. Once isolated, all strains grew
well in liquid media. Six of these strains were previously reported
and two named as type strains for the families Mooreiaceae
(strain CNX-216T) and Catalimonadaceae (CNU-914T) as part
of a separate study (Choi et al., 2013).Chemistry & Biology 22, 1270–127Phylogenetic Analysis and Taxonomic Novelty
A phylogenetic analysis of the 20 strains isolated as part of this
study revealed that they are broadly distributed within five orders
and two bacterial phyla (Bacteroidetes and Proteobacteria), with
themajority (17 strains) belonging to theBacteroidetes (Figure 2).
Based on their phylogenetic relationships and a comparison of
16S rRNA gene sequence identity (SI) with the closest type
strains, these cultured bacteria represent candidates for one
new family, seven new genera, and one new species in addition
to the two new families that have already been described (Choi
et al., 2013) (Table 1). The candidate new family shares <86%
SI with the nearest type strain and clades exclusively with9, September 17, 2015 ª2015 Elsevier Ltd All rights reserved 1271
Figure 2. Phylogeny
16S rRNA maximum-likelihood phylogeny for the 20 strains studied here (bold), the most closely related type strains (indicated by T), and the five closest BLAST
matches. New and candidate new taxa are indicated. Bootstrap valuesR50% (from 1,000 replicates) are shown at their respective nodes.
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Table 1. Bacteria Used in This Study
Number Strain (Accession Number) Phylum Class Order Family
Closest Type Strain
(Accession Number)
(% Identity)
Taxonomic
Novelty
Top BLAST Matcha
Culture
Dependent
Culture
Independent
1 Mooreia alkaloidigenab
CNX-216T (JN368460)
Bacteroidetes Cytophagia Cytophagales Mooreiaceae itself new family 1 TSc 86.0
2 Catalinimonas alkaloidigenab
CNU-914T (JN368461)
Catalimonadaceae itself new family 2 TS 96.9
3 CNU-916 (JN703503) C. alkaloidigena
CNU-914T (JN368461) (99.0)
TS 97.0
4 CUA-436 (KJ572262) C. alkaloidigena
CNU-914T (JN368461) (91.6)
TS 94.4
5 CNX-520 (JN703502) Flammeovirgaceae Tunicatimonas pelagia
N5DB8-4T (AB602437) (96.3)
new genus 1 TS 90.2
6 CNU-893 (JN703500) T. pelagia N5DB8-4T
(AB602437) (93.9)
TS 87.7
7 CUA-287 (JN703501) T. pelagia N5DB8-4T
(AB602437) (94.2)
TS 87.9
8 CNU-872 (KJ572264) T. pelagia N5DB8-4T
(AB602437) (97.4)
TS 96.7
9 CNU-932 (KJ572263) Cytophagaceae Pontibacter odishensis
JC130T (97.0)
new genus 2 TS 94.3
10 CUA-116 (KJ572265) Sphingobacteria Sphingobacteriales Saprospiraceae Lewinella marina MKG-38T
(94.9)
new genus 3 TS 94.7
11 CUA-451 (KJ572266) L. marina MKG-38T (95.6) TS 92.7
12 CUA-466 (KJ572267) L. marina MKG-38T (91.9) TS 93.5
13 CUA-621 (KJ572268) L. marina MKG-38T (92.9) TS 93.5
14 CUA-101 (KJ572269) Flavobacteriia Flavobacteriales Flavobacteriaceae Robertkochia marina
CC-AMO-30DT (97.3)
new genus 4 TS 96.5
15 CUA-420 (KJ572270) Aquimarina gracilis
PSC32T (92.8)
new genus 5 94.0 94.9
16 CUA-117 (KJ572271) Muricauda lutaonensis
CC-HSB-11T (94.4)
new genus 6 TS 98.8
17 CUA-158 (KJ572272) M. lutaonensis CC-HSB-11T
(92.1)
99.4 99.9
18 CUA-171 (KJ572273) Proteobacteria Alphaproteobacteria Rhodobacterales Rhodobacteraceae Paracoccus rhizosphaerae
CC-CCM15-8T (95.6)
new genus 7 TS 94.6
19 CNX-438 (KJ572274) Parvularculales Parvularculaceae Parvularcula dongshanensis
SH25T (85.8)
new family 3 TS 95.2
20 TAA-239 (KJ572275) P. dongshanensis SH25T
(98.1)
new
species 1
TS 96.9
aNot including strains from this study.
bFrom Choi et al., 2013
cTS, type strain. Similarity (%) is similarity with closest type strain identity of the left column.
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Table 2. Results of Agar Plate-Assay Disc Antimicrobial Testing
for Six Culture Organic Extracts
Organic
Extracts
CNJ-912
Pontibacillus sp.
(mm)
CUA-364
Vibrio shiloi
(mm)
CNC-294
Undefined
Marine Yeast
CNU-916 18 10 not active
CUA-287 17 9 not active
CNU-893 14 not active not active
CUA-436 12 not active not active
CUA-116 10 not active not active
CUA-417 14 not active not activesequences that have only been reported using culture-indepen-
dent techniques, indicating that strain CNX-438 represents the
first cultured member of this candidate family. The seven candi-
date genera all share <98% SI (91.9%–97.4%) with the nearest
type strains. Some of these strains, such asCUA-117 (newgenus
6), also form diverse clades with sequences that have only been
reported using culture-independent techniques. Others, such as
those comprising candidate new genus 3, are embedded in
clades within previously described genera, in this case Lewinella
spp. The extraordinary level of diversity encompassed by candi-
date new genus 3 and the rest of the Lewinella clade suggest that
this lineage warrants taxonomic revision. The single strain
cultured in the family Mooreiaceae (CNX-216T) indicates that
this taxon has not been previously cultured or even observed us-
ing culture-independent techniques.
Secondary Metabolite Production and Antibacterial
Activity
Given the taxonomic novelty of these strains, we next tested their
potential to produce novel secondary metabolites with a focus
on antibiotic discovery. We screened for activity against the
Gram-positive marine bacterium Pontibacillus sp. (strain CNJ-
912) isolated from marine sediments (Gontang et al., 2007) and
the Gram-negative marine bacterium Vibrio shiloi (CUA-364), a
known coral pathogen (Kushmaro et al., 2001), as well as an un-
defined marine yeast, our strain CNC-294. We used marine
strains for testing based on the concept that marine bacteria-
produced antibiotics may preferentially target competing marine
bacteria. Organic extracts from five strains (CNU-893, CNX-
216T, CUA-116, CUA-436, and CUA-451) were active against
Pontibacillus sp. while two strains (CNU-916 and CUA-287)
were active against both V. shiloi and Pontibacillus sp. (Tables 2
and S1). Of these, Mooreia alkaloidigena (CNX-216T) generated
some of the more potent antibiotic activities and was thus sub-
jected to detailed chemical analysis, while chemical studies of
Catalinimonas alkaloidigena (CNU-914T) were pursued because
it was the type strain for the new family Catalimonadaceae.
None of the extracts inhibited the marine yeast strain. Strains
CNX-216T and CNU-914T were cultured in replicate 1-l scale,
the whole cultures were extracted with ethyl acetate, and a com-
bination of bioassay-guided purification and chemical screening
was used to isolate 14 alkaloid secondary metabolites belonging
to four structural classes (Figure 3). Of these, compounds 1–9
represent new structures, compounds 1–4, 8, and 9 represent
new carbon skeleton structure classes, and compounds 2, 7,1274 Chemistry & Biology 22, 1270–1279, September 17, 2015 ª201and 9 represent new antibiotic structure types. The antibiotic ac-
tivities of the alkaloids isolated are shown in Table 3.
The structure elucidation of the new compounds entailed
comprehensive utilization of high-resolution mass spectrometry
coupled with one- and two-dimensional nuclear magnetic
resonance (NMR) analyses. A complete discussion of the struc-
ture elucidations of compounds 1–14, including spectra and
detailed discussion of the assignment of relative and absolute
configurations, where appropriate, can be found in the support-
ing information.
Strain CNX-216T was the more prolific alkaloid producer
yielding the new compounds marinoazepinones A and B (1 and
2), marinoaziridines A and B (3 and 4), and marinoquinolines
G–I (5–7) (Figure 3). Both strains CNX-216T and CNU-914T
yielded a fourth series of new compounds that we have called
the marinopyrazinones A and B (8 and 9). Marinoazepinones A
and B (1 and 2) possess an azepin-3-one moiety. To the best
of our knowledge, the marinoazepinones are the first examples
of natural products bearing an azepin-3-one functionality. Mari-
noazepinones A and B also incorporated the unusual, but
known, amino acid, 4-hydroxyphenylglycine, which was previ-
ously reported in a few natural products, such as the complesta-
tin family (isocomplestatins and chloropeptins). Complestatins
are bicylic hexapeptides that possess 4-hydroxyphenylglycine,
three modified 4-hydroxyphenylglycines, and tyrosine and tryp-
tophan residues. Complestatins were originally isolated from a
Streptomyces sp. in 1980 (Kaneko et al., 1989) and were shown
to exhibit various biological activities such as inhibition of sys-
temic anaphylactic shock (Kaneko et al., 1980), inhibition of
gp120-CD4 binding (Matsuzaki et al., 1994), and inhibition of
HIV integrase (Singh et al., 2001).
Marinoaziridines A and B (3 and 4) are the first aziridine-con-
taining natural products isolated from Gram-negative bacteria.
Other natural products containing an aziridine functionality
include mitomycin, ficellomycin, azinomycin, and azicemicin,
isolated fromGram-positive bacteria. The azicemicins were orig-
inally isolated from the genus of Amycolatopsis and were shown
to have antimicrobial activity against Gram-positive bacteria
(Tsuchida et al., 1993, 1995a, 1995b), while mitomycins (Hata
et al., 1956), ficellomycins (Kuo et al., 1989), and azinomycins
are produced by Gram-positive bacteria of the genus Strepto-
myces and showed antitumor and antimicrobial activities (Na-
gaoka et al., 1986; Yokoi et al., 1986). Some aziridine-containing
compounds have also been isolated from marine invertebrates
(Schaschke, 2004; Salomon et al., 1995).
We also report the isolation of marinoquinolines G–I (5–7),
three new metabolites related to the previously described mari-
noquinoline A (10) (Sangnoi et al., 2008). Marinoquinoline A (10)
was originally isolated from Rapidithrix thailandica, also a mem-
ber of the phylum Bacteroidetes. Marinoquinoline A (10) pos-
sesses a pyrroloquinoline moiety and has been reported as an
acetylcholinesterase inhibitor (Sangnoi et al., 2008). Marinoqui-
nolines B–F (structures not shown) were previously isolated
from Ohtaekwangia korrensis (Okanya et al., 2011). These
compounds showed moderate cytotoxicity to mammalian cell
lines and inhibitory activity against the malaria parasite Plasmo-
dium falciparum KI. This species is also a member of the phylum
Bacteroidetes and, like many of the strains reported here, was
isolated using low-nutrient media (Yoon et al., 2011). Among5 Elsevier Ltd All rights reserved
Figure 3. Alkaloidal Metabolites
Chemical structures of secondary metabolites
isolated from two strains, M. alkaloidigena (CNX-
216T) and C. alkaloidigena (CNU-914T).the new marinoquinolines reported here, three alkaloids,
compounds 10–12, displayed antibiotic activity against
Pontibacillus sp.
Marinopyrazinones A and B (8 and 9) are the first pyrazinone
natural products isolated from Gram-negative bacteria. Other
pyrazinone-containing microbial natural products have been
previously reported from the fungus Aspergillus sp. and from
Gram-positive bacteria of the genus Streptomyces (Tatsuta
et al., 1971). The compound arglecin, isolated from an Asper-
gillus sp., is the most well-known metabolite because of its anti-
arrhythmic activity. The compound phevalin, produced by a
Streptomyces sp., showed inhibitory activity against calpain, a
Ca2+-dependent cysteine protease, a promising molecular
target for the treatment of neurodegenerative and muscular
dystrophy diseases (Alvarez et al., 1995). Recently, two new
pyrazinone compounds were isolated from the human pathogen
Staphylococcus aureus following bioinformatics data analysis
(Zimmermann and Fischbach, 2010). The bioinformatics
method provided gene sequences that are conserved across
all sequenced strains of the human-pathogenic bacterium
S. aureus. Three pyrazinone secondary metabolites encodedChemistry & Biology 22, 1270–1279, September 17, 2015 ªby this nonribosomal peptide gene clus-
ter regulate S. aureus virulence factor
expression and are essential for the
expression of a viable infection in a
mouse model (Wyatt et al., 2010).
DISCUSSION
Molecular surveys reveal that the vast
majority of bacterial diversity has yet to
be obtained in culture (Rappe´ and Gio-
vannoni, 2003). This gap between what
can be observed in the environment and
what can be studied in the laboratory
severely hampers efforts to exploit bacte-
ria for well-established biomedical pur-
poses such as antibiotic discovery. Using
relatively simple methods including low-
nutrient agar media and long incubation
times, 20 taxonomically diverse strains
of Gram-negative bacteria within the
phyla Bacteroidetes and Proteobacteria
were cultured. These strains include as
many as three new families and seven
new genera, indicating that considerable
new microbial diversity can be readily
cultured with minimal effort. Chemical
studies of two of these strains revealed
they are a rich source of alkaloid second-
ary metabolites including new antibiotics
and three new structural classes. Whileit is well known that long incubation times (Stevenson et al.,
2004) and low-nutrient media (Connon and Giovannoni, 2002;
Janssen et al., 2002) facilitate bacterial culturability, these tech-
niques are generally not applied to the isolation of strains used
for antibiotic discovery.
Bacteria in the phylum Bacteroidetes are known to be domi-
nant members of soil communities (Fierer et al., 2007) and
have been isolated from diverse environments including marine
sediments (Choi et al., 2013). While previously recognized for
the production of antibiotics (Keller and Zengler, 2004), this
phylum and other Gram-negative taxa have traditionally been
overlooked in the search for new antibiotics in favor of more
traditional microbial resources such as Streptomyces spp. Me-
tabolites previously reported from the Bacteroidetes include
flexirubin and other carotenoids, which are used as chemotaxo-
nomic markers (Reichenbach, 2006; Schmidt et al., 2006), and a
series of volatile polysulfides from two Cytophaga strains (Sobik
et al., 2007). A prior study by our group on the glidingmarine bac-
terium Saprospira grandis within the order Cytophagales led to
the isolation of four new diterpenoids of the neoverrucosane
class (Spyere et al., 2003). Similarly, a gliding marine bacterium2015 Elsevier Ltd All rights reserved 1275
Table 3. Results of Agar Plate-Assay Disc Antimicrobial Testing
for Alkaloids 1–14
Pure Compounds
1–14 (50 mg/disc)
Strain CNJ-912
Pontibacillus sp.
(mm)
Strain
CUA-364
Vibrio shiloi
Strain
CNC-294
Undefined
Marine Yeast
Marinoazepinone A (1) not active not active not active
Marinoazepinone B (2) 16 not active not active
Marinoaziridine A (3) not active not active not active
Marinoaziridine A (4) not active not active not active
Marinoquinoline G (5) not active not active not active
Marinoquinoline H (6) not active not active not active
Marinoquinoline I (7) 18 not active not active
Marinopyrazinone A (8) not active not active not active
Marinopyrazinone B (9) 14 9 not active
Marinoquinoline A (10) 11 not active not active
Marinoquinoline C (11) 16 not active not active
Marinoquinoline D (12) 9 not active not active
Marinoquinoline K (13) not active not active not active
Marinoquinoline J (14) not active not active not active
Rifamycin 5 mg 42
Ciprofloxacin 5 mg 16in the genus Rapidithrix was the source of the hybrid NRPS-PKS
antibiotics ariakemicin A and B (Oku et al., 2008). Among the
compounds isolated here are three new derivatives in the mari-
noquinoline class (5–7). Related compounds in this series were
previously reported from R. thailandica and Ohtaekwangia krib-
bensis, suggesting that they may represent a common feature
of the order Cytophagales.
Biosynthetically, the modification of a variety of amino acid
residues can obviously explain the diversity of structures pro-
duced by these strains. The side chains in the marinoquinolines
and marinoazepinones, for example, can all be hypothesized to
be derived from various amino acids. All three of the knownmar-
inoquinoline-producing genera belong to the order Cytopha-
gales (phylum Bacteroidetes), suggesting that this amino acid-
based biosynthesis may be a common feature of this order.
The origins of several of the alkaloids isolated here are less confi-
dently suggested. Clearly, genomic analysis and annotation
would be important as a starting point to assess the biosynthetic
origins of the marinoaziridines and marinopyrazinones. The
mechanisms of action and molecular targets of the antibacterial
alkaloids 2, 7, and 8–12, would be of significant interest. Some of
these activities may simply be a function of the known antibacte-
rial effects of phenolics, but in other cases this functionality is ab-
sent, leading to less confident speculation.
In summary, we report the isolation of 20 taxonomically
diverse, Gram-negative bacteria from numerous marine sources
including members of as many as three new families within the
phylum Bacteroidetes. Key to the cultivation of these strains
was the use of low-nutrient media and untraditionally long incu-
bation times. Of importance is that two of these strains, the type
strains CNX-216T and CNU-914T, produce new alkaloid second-
ary metabolites, several of which represent new carbon skele-
tons and possess antibacterial activities. Our studies provide1276 Chemistry & Biology 22, 1270–1279, September 17, 2015 ª201support for the use of low-nutrient media and long incubation
times in the search for new antibiotics frompreviously uncultured
Gram-negative marine bacteria.
SIGNIFICANCE
This study illustrates that slightly modified but simple culti-
vation techniques can readily lead to the recovery of bacte-
ria that were previously assigned to the ‘‘uncultured major-
ity’’ including new genus and family level lineages.
Chemical studies reveal these strains can be a rich source
of new alkaloid secondary metabolites, including some
that possess antibiotic activities. The results suggest that
many new groups of bacteria can be readily isolated for nat-
ural product discovery efforts and that these strains can
represent an important resource for antibiotic and other
biomedical discovery.
EXPERIMENTAL PROCEDURES
Bacterial Isolation and Cultivation
Marine samples were collected from various locations in sterileWhirl-Pac bags
at depths ranging from <1 m to 29 m. Samples were processed as described
below (isolation methods 1–7) and in Tables S1 and S2. Plates were checked
weekly for emergence of new colonies for the first month and every other week
thereafter. Strains were selected for isolation based on pigmentation and
morphological features, and obtained in pure culture as previously described
(Jensen et al., 2005; Choi et al., 2013).
Method 1
Sediment samples were dried overnight in a laminar flow hood and ‘‘stamped’’
onto the surface of P1, P3, P8, and P11 agar plates using 0.2-cm diameter
sterile foam plugs (Jensen et al., 2005).
Method 2
Approximately 1 g of wet sediment was volumetrically added to 4 ml of sterile
seawater (SSW), vortex mixed, and heat-shocked at 55C for 9 min, and 25 ml
was inoculated onto P3 agar plates and spread with a sterilized glass rod.
Method 3
Approximately 1 g of wet sediment was volumetrically added to 1 ml of SSW,
vortex mixed, and diluted 1:10 in SSW, and 25 ml was inoculated onto P4 agar
plates and spread with a sterilized glass rod.
Method 4
Approximately 1 g of algae or soft coral was added to 4 ml of SSW, vortex
mixed, and diluted 1:4 with SSW, and 25 ml was inoculated onto P10 agar
plates and spread with a sterilized glass rod.
Method 5
Approximately 1 g of sediment or algae was added to 4 ml of SSW, vortex
mixed, and heat-shocked at 55C for 6 min, and 25 ml was inoculated onto
P9 agar plates and spread with a sterilized glass rod.
Method 6
Mangrove aerial roots were dried overnight in a laminar flow hood, homoge-
nized with a mortar and pestle, and stamped onto P5 agar plates with a
0.2-cm diameter sterile foam plug.
Method 7
Epidermal mucus from representative elasmobranch species was collected
with a sterilized spatula after the epidermal surface was rinsed with SSW for
10 s. Approximately 1 ml of mucus was diluted in 1 ml of SSW, vortex mixed,
and further diluted 1:10 in SSW, and 25 ml of each dilution was inoculated onto
A1 and P7 agar plates and spread with a sterilized glass rod.
Agar plates were incubated at room temperature (25C) for a maximum
of 2–3 months and visually inspected weekly for new colonial formation us-
ing a Leica MZ6 stereomicroscope (Leica Microsystems). Bacterial colonies
that presented features such as dry consistency, irregular margin, and yel-
low-orange pigmentation were isolated and obtained in pure culture by
repeated streaking. Each strain was then cultured in A1 or B1 liquid media
(A1: 10.0 g of starch, 4.0 g of yeast extract, 2.0 g of peptone, 750 ml of5 Elsevier Ltd All rights reserved
filtered seawater, 250 ml of deionized water; B1: 2.5 g of peptone, 1.5 g of
yeast extract, 50% glycerol, and 1 l of seawater) for 7 days while shaking at
230 rpm (25C) and cryopreserved in 20% (v/v) glycerol at 80C. In addi-
tion, we prepared crude extracts for bioactivity testing by 1-l cultivation in
A1 liquid medium (10.0 g of starch, 4.0 g of yeast extract, 2.0 g of peptone,
1 l of filtered seawater) and Difco Marine Broth 2216 for 7 days while
shaking at 230 rpm (25C). The cultures were extracted with the same vol-
ume of ethyl acetate, and the ethyl acetate was dried to prepare samples for
bioassay.
Bioactive Tests of Gram-Negative Strains
We tested antibacterial activities against Pontibacillus sp. (strain CNJ-912) and
V. shiloi (strain CUA-364), and also an undefined marine yeast, our strain CNC-
294, using the agar disc-diffusion bioassay method (Bonev et al., 2008). We
added a marine yeast strain to assess eukaryotic activity. V. shiloi is a
Gram-negative coral pathogen in the family Vibrionaceae, while Pontibacillus
sp. is a Gram-positive marine bacterium belonging to the family Bacillaceae.
Overnight cultures of these strains were diluted 1:200 in 0.6% molten agar
at 44C (Difco Marine Agar 2216 and A1 agar for Pontibacillus sp. and
V. shiloi, respectively). Organic culture extracts were reconstituted in ethanol
at 10 mg/ml, and 25 ml was transferred to a paper disc (250 mg per disc). Frac-
tions were reconstituted at 10 mg/ml in ethanol and 5 ml was transferred to a
paper disc (50 mg per disc). After the solvent evaporated, the disc was placed
on the agar platewith each test strain. Negative control discs (solvent only) and
positive control discs (5 mg of ciprofloxacin BBL Sensi-Disc, Cat. No. 231658)
were also placed on test plates.
Phylogenetic Analysis of Gram-Negative Strains
Genomic DNA was obtained from cells derived from agar plates or liquid cul-
tures using the QIAamp DNA Mini Kit (Qiagen). The 16S rRNA gene was PCR
amplified using the universal primers 27f and 1492r (Brosius et al., 1978). The
PCR products were purified using the MinElute PCR purification kit (Qiagen)
and sequenced on a capillary DNA sequencer (Perkin-Elmer model ABI
3730XL, Applied Biosystems) using the ABI Prism Bigdye terminator cycle
sequencing Ready reaction kit v.3.1 (Applied Biosystems). The sequences
were compared with those available in GenBank using BLAST (Altschul
et al., 1990) and the top five matches downloaded. A multiple sequence align-
ment was generated using Clustal W (Thomson et al., 1994) and a maximum-
likelihood phylogeny generated with 1,000 re-sampled datasets (Kimura,
1980; Felsenstein, 1985). A phylogenetic tree was constructed using the pro-
gram MEGA5 (Tamura et al., 2011).
Fermentation and Extraction
Strain CNX-216T was cultured at 27Cwhile shaking at 230 rpm in 803 1-l vol-
umes of medium A1BFe + C (composed of 10 g of starch, 4 g of yeast extract,
2 g of peptone, 1 g of CaCO3, 40 mg of Fe2(SO4)3$4H2O, 100 mg of KBr, per 1 l
of seawater). After 7 days of cultivation, sterilized XAD-16 resin (20 g/l) was
added to adsorb extracellular secondary metabolites. The culture and resin
were shaken at 215 rpm for 2 hr. The resin was filtered through cheesecloth,
washed with deionized water, and eluted with acetone. The acetone was
removed under reduced pressure, and the resulting aqueous layer extracted
with EtOAc (33 500ml). The EtOAc-soluble fractionwas dried in vacuo to yield
4.5 g of extract.
Experimental Procedures for Chemical Analysis
The optical rotations were measured using a Rudolph Research Autopol III
polarimeter with a 10-cm cell. UV spectra were recorded in a Varian Cary
UV-visible spectrophotometer with a path length of 1 cm, and infrared (IR)
spectra were recorded on a Perkin-Elmer 1600 Fourier transform IR spectrom-
eter. Circular dichroism (CD) spectra were collected in an AVIV Model 215 CD
spectrometer with a 0.5-cm long cell. Proton 1D and 2D NMR spectral data
were recorded at 500 or 600MHz in DMSO-d6, CDCl3, or methanol-d4 solution
containing Me4Si as internal standard on Varian Inova spectrometers.
13C
NMR spectra were acquired at 75 MHz on a Varian Inova spectrometer.
High-resolution electrospray ionization time-of-flight mass spectra were pro-
vided by The Scripps Research Institute, La Jolla, CA or the mass spectrom-
etry facility at the Department of Chemistry and Biochemistry at the University
of California, San Diego, La Jolla. Low-resolution liquid chromatography-massChemistry & Biology 22, 1270–127spectrometry (LC-MS) data were measured using a Hewlett-Packard series
1100 LC-MS system with a reversed-phase C18 column (Phenomenex Luna,
4.6 3 100 mm, 5 mm) at a flow rate of 0.7 ml/min.
Isolation of Marinoazepinones 1, 2, Marinoaziridines 3, 4,
Marinoquinolines 5–7 and 10–14, and Marinopyrazinone A 8
The extract (4.5 g) of CNX-216T was fractionated by open column chromatog-
raphy on silica gel (25 g), eluted with a step gradient of CH2Cl2 and MeOH. The
CH2Cl2/MeOH 5:1 fraction contained a mixture of both marinoazepinones and
marinoaziridines, which were purified by reversed-phase high-performance
liquid chromatography (HPLC) (Phenomenex Luna C18(2), 250 3 100 mm,
5 mm, 100 A˚, 2.0 ml/min, UV = 210 nm) using an isocratic solvent system
(H2O/CH3CN = 40:60) to afford marinoazepinones A (1, 18.0 mg),
B (2, 13.0 mg), marinoaziridines A (3, 11.2 mg), B (4, 13.5 mg), and marinopyr-
azinone A (8, 7.5 mg), as pale yellow oils. The CH2Cl2/MeOH 1:1 fraction con-
tained a mixture of marinoquinolines, which was purified by reversed-phase
HPLC (Phenomenex Luna C18(2), 250 3 100 mm, 5 mm, 100 A˚, 2.0 ml/min,
UV = 210 nm) using an isocratic solvent system from 10% to 50% MeOH
(0.01% trifluoroacetic acid) over 50 min to afford marinoquinolines
G (5, 7.0 mg), H (6, 8.3 mg), I (7, 4.5 mg), A (10, 7.1 mg), C (11, 3.0 mg),
D (12,1.5 mg), J (14, 5.0 mg), K (13, 2.4 mg), as pale yellow oils.
Fermentation and Extraction for Isolation of Marinopyrazinone B 9
from Gram-Negative Bacterial Strain CNU-914T
Strain CNU-914T was cultured in 403 1-l volumes of the A1BFe + C liquid me-
dium and shaken at 230 rpm at 27C. After 7 days of cultivation, sterilized XAD-
16 resin (20 g/l) was added to absorb the organic products, and the culture and
resin were shaken at 215 rpm for 2 hr. The resin was filtered through cheese-
cloth, washedwith deionized water, and elutedwith acetone. The acetone was
removed under reduced pressure, and the resulting aqueous layer was ex-
tractedwith EtOAc (33 400ml). The EtOAc-soluble fractionwas dried in vacuo
to yield 3.4 g of extract. The extract (3.4 g) was fractionated by open column
chromatography on silica gel (25 g), eluted with a step gradient of CH2Cl2
and MeOH. The CH2Cl2/MeOH 5:1 fraction was purified by reversed-phase
HPLC (Phenomenex Luna C18(2), 250 3 100 mm, 5 mm, 100 A˚, 2.0 ml/min,
UV = 210 nm) using an isocratic solvent system (H2O/CH3CN = 35:65) to afford
marinopyrazinone B (9, 6.0 mg), as a pale yellow oil.
Physical and Spectral Properties of Alkaloids 1–14
Marinoazepinone A (1): pale yellow oil; [a]D
21 1 (c 0.1, MeOH); UV (MeOH)
lmax (log ε) 238 (4.5), 256 (4.3), 318 (3.9), 380 (3.5) nm; IR (KBr) nmax 3,745,
3,230, 1,616, 1,519, 1,251, 1,025, 757 cm1; 1H and 2D NMR (600 MHz in
DMSO-d4, 500 MHz in MeOH-d4), see Table S3; high-resolution electrospray
ionization mass spectrometry (HRESIMS) [M + H]+ m/z 305.1296 (calcd for
C19H17N2O2, 305.1284).
Marinoazepinone B (2): pale yellow oil; [a]D
21 1 (c 0.1, MeOH); UV (MeOH)
lmax (log ε) 238 (4.5), 256 (4.3), 318 (3.9), 380 (3.5) nm; IR (KBr) nmax 3,745,
3,230, 1,616, 1,519, 1,251, 1,025, 757 cm1; 1H and 2D NMR (500 MHz,
DMSO-d4, MeOH-d4), see Table S4; HRESIMS [M + H]
+ m/z 291.1141 (calcd
for C18H15N2O2, 291.1128).
Marinoaziridine A (3): pale yellow oil; [a]D
21 6 (c 0.1, MeOH); UV (MeOH)
lmax (log ε) 250 (4.3), 282 (3.8), 388 (3.7) nm; IR (KBr) nmax 3,430, 1,670,
1,622, 1,485, 1,341, 942, 771 cm1; 1H and 2D NMR (500 MHz, CDCl3,
MeOH-d4), see Table S5; HRESIMS [M + H]
+ m/z 229.1346 (calcd for
C14H17N2O, 229.1335).
Marinoaziridine B (4): pale yellow oil; [a]D
21 6 (c 0.1, MeOH); UV (MeOH)
lmax (log ε) 250 (4.3), 282 (3.8), 388 (3.7) nm; IR (KBr) nmax 3,433, 1,671,
1,624, 1,481, 1,340, 941, 773 cm1; 1H and 2D NMR (500 MHz, CDCl3,
MeOH-d4), see Table S6; HRESIMS [M + H]
+ m/z 215.1185 (calcd for
C13H15N2O, 215.1179).
Marinoquinoline G (5): pale yellow oil; UV (MeOH) lmax (log ε) 226 (4.6), 240
(4.6), 301 (4.1), 314 (4.0), 327 (3.8) nm; IR (KBr) nmax 3,310, 1,506, 1,217,
770 cm1; 1H and 2D NMR (500 MHz, MeOH-d4), see Table S7; HRESIMS
[M + H]+ m/z 197.1084 (calcd for C13H13N2, 197.1079).
Marinoquinoline H (6): pale yellow oil; UV (MeOH) lmax (log ε) 227 (4.6), 241
(4.6), 303 (4.1), 315 (4.0), 328 (3.8) nm; IR (KBr) nmax 3,312, 1,504, 1,218,
770 cm1; 1H and 2D NMR (500 MHz, MeOH-d4), see Table S8; HRESIMS
[M + H]+ m/z 261.1034 (calcd for C17H13N2O, 261.1022).9, September 17, 2015 ª2015 Elsevier Ltd All rights reserved 1277
Marinoquinoline I (7): pale yellow oil; UV (MeOH) lmax (log ε) 226 (4.6), 240
(4.6), 301 (4.1), 313 (4.0), 329 (3.8) nm; IR (KBr) nmax 3,312, 1,670, 1,504,
1,218, 770 cm1; 1H and 2D NMR (500 MHz, MeOH-d4), see Table S9;
HRESIMS [M + H]+ m/z 282.1625 (calcd for C17H20N3O, 282.1606).
Marinopyrazinone A (8): pale yellow oil; UV (MeOH) lmax (log ε) 226 (4.6), 295
(3.8), 328 (4.4) nm; IR (KBr) nmax 3,025, 2,971, 1,691, 1,621, 1,457, 1,358 cm
1;
1H and 2D NMR (500 MHz, CDCl3, MeOH-d4), see Table S10; HRESIMS [M +
Na]+ m/z 335.2093 (calcd for C20H28N2ONa, 335.2094).
Marinopyrazinone B (9): pale yellow oil; UV (MeOH) lmax (log ε) 226 (4.6), 294
(3.8), 326 (4.4) nm; IR (KBr) nmax 3,024, 2,970, 1,692, 1,623, 1,455, 1,357 cm
1;
1H and 2D NMR (500 MHz, CDCl3, MeOH-d4), see Table S11; HRESIMS
[M + H]+ m/z 357.2536 (calcd for C22H33N2O2, 357.2537).
Marinoquinoline A (10): 1HNMR (500MHz,MeOH-d4): d 8.50 (1H, dd, J = 7.8,
1.2 Hz), 8.19 (1H, d, J = 2.4 Hz), 8.07 (1H, dd, J = 7.8, 1.2 Hz), 7.85 (1H, dd, J =
7.8, 7.8 Hz), 7.83 (1H, dd, J = 7.8, 7.8 Hz), 7.46 (1H, d, J = 2.4 Hz), 3.14 (3H, s);
LC-MS [M+H]+m/z 183; [M +Na]+m/z 205. Comparable with literature values,
see Okanya et al., 2011.
Marinoquinoline C (11): 1H NMR (500 MHz, DMSO-d6): d 8.56 (1H, dd, J =
7.8, 1.2 Hz), 8.34 (1H, d, J = 2.4 Hz), 8.21 (1H, dd, J = 7.8, 1.2 Hz), 7.85 (1H,
dd, J = 7.8, 7.8 Hz), 7.81 (1H, dd, J = 7.8, 7.8 Hz), 7.56 (1H, d, J = 2.4 Hz),
7.46 (2H, dd, J = 7.8, 1.0 Hz), 7.30 (2H, dd, J = 7.8, 7.8 Hz), 7.24 (1H, dd, J =
7.8, 1.0 Hz), 4.82 (2H, s); see also Table S12. LC-MS [M + H]+ m/z 259; [M +
Na]+ m/z 281.
Marinoquinoline D (12): 1H NMR (500 MHz, MeOH-d4): d 8.50 (1H, dd, J =
7.8, 1.2 Hz), 8.12 (1H, dd, J = 7.8, 1.2 Hz), 7.84 (1H, dd, J = 7.8, 7.8 Hz),
7.81 (1H, dd, J = 7.8, 7.8 Hz), 8.12 (1H, d, J = 2.4 Hz),7.46 (1H, d, J =
2.4 Hz), 7.17 (2H, d, J = 7.8 Hz), 6.75 (2H, d, J = 7.8 Hz), 4.67 (2H, s); see
also Table S13. LC-MS [M + H]+ m/z 275; [M + Na]+ m/z 297.
Marinoquinoline K (13): 1H NMR (500 MHz, MeOH-d4): d 9.33 (1H, s), 8.62
(1H, dd, J = 7.8, 1.2 Hz), 8.30 (1H, d, J = 2.4 Hz), 8.17 (1H, dd, J = 7.8,
1.2 Hz), 7.94 (1H, dd, J = 7.8, 7.8 Hz), 7.90 (1H, dd, J = 7.8, 7.8 Hz), 7.55
(1H, d, J = 2.4 Hz); see also Table S14. LC-MS [M + H]+ m/z 169; [M + Na]+
m/z 191.
Marinoquinoline J (14): 1H NMR (500 MHz, MeOH-d4): d 9.47 (1H, s), 8.66
(1H, dd, J = 7.8, 1.2 Hz), 8.37 (1H, dd, J = 7.8, 1.2 Hz), 8.29 (1H, d, J =
2.4 Hz), 8.02 (1H, dd, J = 7.8, 7.8 Hz), 7.95 (1H, dd, J = 7.8, 7.8 Hz), 7.54
(1H, d, J = 2.4 Hz), 4.60 (3H, s); see also Table S15. LC-MS [M + H]+ m/z
183; [M + Na]+ m/z 205.
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